Medicalmanagement of prostate cancermeans doubled life expectancy for some men
Prostate cancer is the second most common cause of death related to cancer in Australian men. An article in the latest edition of Australian Prescriber offers guidance on how to manage prostate cancer that has spread to other parts of the body.
Medical oncologist Ganes Pranavan and colleagues from Canberra and Royal Adelaide Hospitals say reducing the amount of male hormones is an important part of treatment. If the cancer has spread despite this therapy, there are now several options to improve survival outlined in the article.
Dr Pranavan says, “Advances in treatment mean that, for some men, prostate cancer is now considered a chronic illness. Their life expectancy has almost doubled.”
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals. It is published by NPS MedicineWise, an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health. Australian Prescriber is published every two months and is available online at nps.org.au/australianprescriber